Staphylococcus capitis isolated from bloodstream infections: a nationwide 3-month survey in 38 neonatal intensive care units.

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
Marie DecalonneNathalie Van Der Mee-Marquet

Abstract

To increase the knowledge about S. capitis in the neonatal setting, we conducted a nationwide 3-month survey in 38 neonatal intensive care units (NICUs) covering 56.6% of French NICU beds. We demonstrated 14.2% of S. capitis BSI (S.capBSI) among nosocomial BSIs. S.capBSI incidence rate was 0.59 per 1000 patient-days. A total of 55.0% of the S.capBSIs were late onset catheter-related BSIs. The S. capitis strains infected preterm babies (median gestational age 26 weeks, median birth weight 855 g). They were resistant to methicillin and aminoglycosides and belonged to the NRCS-A clone. Evolution was favorable in all but one case, following vancomycin treatment.

References

Sep 25, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G D de SilvaS J Peacock
Jun 29, 2002·Journal of Clinical Microbiology·Wil C Van Der ZwetChristina M J E Vandenbroucke-Grauls
Sep 21, 2006·The Journal of Hospital Infection·P Gastmeier, C Geffers
Sep 7, 2007·Journal of Perinatology : Official Journal of the California Perinatal Association·C Gras-Le GuenD Lepelletier
Apr 5, 2011·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Craig A UmscheidPatrick J Brennan
Sep 26, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M ButinF Laurent
Aug 29, 2018·Antimicrobial Agents and Chemotherapy·Glen P CarterDeborah A Williamson
Sep 21, 2018·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Peter W SchreiberUNKNOWN Swissnoso
Apr 1, 2019·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·F Laurent, M Butin
Aug 10, 2019·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Bianca StenmarkBo Söderquist

❮ Previous
Next ❯

Citations

Jul 16, 2021·Current Opinion in Infectious Diseases·Brandon R Hadfield, Joseph B Cantey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.